Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis. Initial experience of a cancer center in Brazil No significant financial ...

Please provide your email address to receive an email when new articles are posted on . At the end of induction, 56% of patients treated with subcutaneous guselkumab vs. 21% on placebo achieved ...

Sequential chemoradiotherapy versus induction chemotherapy plus concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: A multicentre, open-label, non-inferiority, ...